Looks like The Trade Desk is getting a little after hours bump too (+3.4% AH). I’m guessing the assumption is that if ROKU is doing well, that must mean companies are still spending on advertising, which helps TTD.
LVGO has been one I have added to my port over last two months. We should talk more about them on the boards.
I agree. Diabetes unfortunately afflicts a ton of people. LVGO offers a product that is a new support option. Very important is that the guy who decides to use it is spending the insurance company’s money, not his own. And the insurance company sees it as a money-saver to them. So to the consumer, cost is not of concern and the benefits can be life-saving and the insurer sees a bargain. Nice for LVGO.
Update revenue to $307M to $317M up from $300M to $310M. Raising growth rate at top from 49% to 54%.
We’ve seen some reaffirms but this is the first raise I think. Correct me if that’s not correct.</>
This represents a modest change in expectations. The article offers no further surprises and guidance is withdrawn… So why is ROKU up so much (to 106 ) in after hours trading?
This represents a modest change in expectations. The article offers no further surprises and guidance is withdrawn… So why is ROKU up so much (to 106 ) in after hours trading?
The market is all about pricing in expectations. There has been competing thoughts as to how the economic realities around businesses that have advertising as a core revenue driver. On one hand many industries are decreasing or halting advertising. On the other hand Roku is seeing a spike in home viewing on CTV. The market has driven Roku’s stock price without knowledge of what is actually going on. Some could argue that the price movement is reflecting a belief that Roku ad revenue would cause them to miss estimates, in some arguments by a lot.
So not only is the market not considering that revenue will fall below expectations but is actually raising guidance for this first effected quarter(a month really). The alpha between expectations and reality is greater than the alpha between original forecast and update.
I agree. Diabetes unfortunately afflicts a ton of people. LVGO offers a product that is a new support option. Very important is that the guy who decides to use it is spending the insurance company’s money, not his own. And the insurance company sees it as a money-saver to them. So to the consumer, cost is not of concern and the benefits can be life-saving and the insurer sees a bargain. Nice for LVGO.
Plus, obesity fueled diabetes is getting a boost from having to stay at home. Overeating has gone up for many, with less exercise to offset it.